Figure 7.
Sensitivity analysis, forest plot comparing risk of incident diabetes mellitus among interventions in trials with sample sizes ≥500 patients and follow‐up ≥1 year. PCSK9 indicates proprotein convertase subtilisin/kexin type 9.
Sensitivity analysis, forest plot comparing risk of incident diabetes mellitus among interventions in trials with sample sizes ≥500 patients and follow‐up ≥1 year. PCSK9 indicates proprotein convertase subtilisin/kexin type 9.